These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30683446)

  • 1. Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations.
    Girmenia C; Cavo M; Offidani M; Scaglione F; Corso A; Di Raimondo F; Musto P; Petrucci MT; Barosi G
    Blood Rev; 2019 Mar; 34():84-94. PubMed ID: 30683446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations.
    Girmenia C; Candoni A; Delia M; Latagliata R; Molteni A; Oliva EN; Palumbo GA; Poloni A; Salutari P; Santini V; Voso MT; Musto P
    Blood Rev; 2019 Mar; 34():16-25. PubMed ID: 30448050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of infectious risk of daratumumab therapy in multiple myeloma: A consensus-based position paper from an ad hoc Italian expert panel.
    Girmenia C; Cavo M; Corso A; Di Raimondo F; Musto P; Offidani M; Petrucci MT; Rosato A; Barosi G
    Crit Rev Oncol Hematol; 2022 Apr; 172():103623. PubMed ID: 35151867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology.
    Zinzani PL; Rambaldi A; Gaidano G; Girmenia C; Marchetti M; Pane F; Tura S; Barosi G
    Leuk Res; 2019 Jun; 81():88-94. PubMed ID: 31055248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an
    De Stefano V; Larocca A; Carpenedo M; Cavo M; Di Raimondo F; Falanga A; Offidani M; Petrucci MT; Ruggeri M; Santi RM; Barosi G
    Haematologica; 2022 Nov; 107(11):2536-2547. PubMed ID: 35861017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia.
    Tadmor T; Welslau M; Hus I
    Expert Rev Hematol; 2018 Jan; 11(1):57-70. PubMed ID: 29160119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination in Multiple Myeloma: Review of Current Literature.
    Alemu A; Richards JO; Oaks MK; Thompson MA
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):495-502. PubMed ID: 27364264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma.
    Teh BW; Reynolds G; Slavin MA; Cooley L; Roberts M; Liu E; Thursky K; Talaulikar D; Mollee P; Szabo F; Ward C; Chan H; Prince HM; Harrison SJ;
    Intern Med J; 2023 Aug; 53(8):1469-1477. PubMed ID: 37093163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel.
    Raje N; Anderson K; Einsele H; Efebera Y; Gay F; Hammond SP; Lesokhin AM; Lonial S; Ludwig H; Moreau P; Patel K; Ramasamy K; Mateos MV
    Blood Cancer J; 2023 Aug; 13(1):116. PubMed ID: 37528088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
    Raje NS; Anaissie E; Kumar SK; Lonial S; Martin T; Gertz MA; Krishnan A; Hari P; Ludwig H; O'Donnell E; Yee A; Kaufman JL; Cohen AD; Garderet L; Wechalekar AF; Terpos E; Khatry N; Niesvizky R; Yi Q; Joshua DE; Saikia T; Leung N; Engelhardt M; Mothy M; Branagan A; Chari A; Reiman AJ; Lipe B; Richter J; Rajkumar SV; Miguel JS; Anderson KC; Stadtmauer EA; Prabhala RH; McCarthy PL; Munshi NC
    Lancet Haematol; 2022 Feb; 9(2):e143-e161. PubMed ID: 35114152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA).
    Bringhen S; Milan A; Ferri C; Wäsch R; Gay F; Larocca A; Salvini M; Terpos E; Goldschmidt H; Cavo M; Petrucci MT; Ludwig H; Auner HW; Caers J; Gramatzki M; Boccadoro M; Einsele H; Sonneveld P; Engelhardt M;
    Haematologica; 2018 Sep; 103(9):1422-1432. PubMed ID: 30049825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of infections pre- and post-liver transplantation: report of an AISF consensus conference.
    Fagiuoli S; Colli A; Bruno R; Craxì A; Gaeta GB; Grossi P; Mondelli MU; Puoti M; Sagnelli E; Stefani S; Toniutto P; Burra P;
    J Hepatol; 2014 May; 60(5):1075-89. PubMed ID: 24384327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.
    Durie BG; Kyle RA; Belch A; Bensinger W; Blade J; Boccadoro M; Child JA; Comenzo R; Djulbegovic B; Fantl D; Gahrton G; Harousseau JL; Hungria V; Joshua D; Ludwig H; Mehta J; Morales AR; Morgan G; Nouel A; Oken M; Powles R; Roodman D; San Miguel J; Shimizu K; Singhal S; Sirohi B; Sonneveld P; Tricot G; Van Ness B;
    Hematol J; 2003; 4(6):379-98. PubMed ID: 14671610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.
    Peñalver FJ; Delgado J; Loscertales J; Sastre JL; Peña A; Olave MT; Osorio S; de la Fuente A; Salar A; Grande C; Pérez Ceballos E; Debén G; Echeveste A; Casado F; de la Rubia J; Lahuerta JJ; Mateos MV
    Eur J Haematol; 2016 May; 96(5):532-40. PubMed ID: 26179864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy.
    Teh BW; Harrison SJ; Worth LJ; Spelman T; Thursky KA; Slavin MA
    Br J Haematol; 2015 Oct; 171(1):100-8. PubMed ID: 26105211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].
    Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J
    Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.
    Ludwig H; Boccadoro M; Moreau P; San-Miguel J; Cavo M; Pawlyn C; Zweegman S; Facon T; Driessen C; Hajek R; Dimopoulos MA; Gay F; Avet-Loiseau H; Terpos E; Zojer N; Mohty M; Mateos MV; Einsele H; Delforge M; Caers J; Weisel K; Jackson G; Garderet L; Engelhardt M; van de Donk N; Leleu X; Goldschmidt H; Beksac M; Nijhof I; Abildgaard N; Bringhen S; Sonneveld P
    Leukemia; 2021 Jan; 35(1):31-44. PubMed ID: 32814840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety issues and management of toxicities associated with new treatments for multiple myeloma.
    Brioli A; Mügge LO; Hochhaus A; Von Lilienfeld-Toal M
    Expert Rev Hematol; 2017 Mar; 10(3):193-205. PubMed ID: 28116920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Belgian 2010 consensus recommendations for the treatment of multiple myeloma.
    Schots R; Delforge M; André M; Bries G; Caers J; Demuynck H; De Prijck B; De Samblanx H; Kentos A; Meuleman N; Offner F; Vekemans MC; Vande Broek I; Van Droogenbroeck J; Van de Vanelde A; Wu KL; Doyen C;
    Acta Clin Belg; 2010; 65(4):252-64. PubMed ID: 20954465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing renal complications in multiple myeloma.
    Fotiou D; Dimopoulos MA; Kastritis E
    Expert Rev Hematol; 2016 Sep; 9(9):839-50. PubMed ID: 27426872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.